RAG2 and Hepatic fibrosis: demonstrated that treatment of liver fibrosis with a population of human iPSC-derived M2 subtype macrophages in an immunodeficient Rag2 γc mouse model significantly reduced the expression of fibrotic genes, including DES (63).